Fiche centre
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan — Italy
Essais liés7clinical trials
VilleMilanlocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03742037
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Emapalumab | Lupus | Phase 3 | NCT05001737 | EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE | COMPLETED |
| Anifrolumab | Lupus | À vérifier | NCT07330245 | DAHLIA — Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab. | RECRUITING |
| Cenerimod 0.5 mg | Lupus | Phase 2 | NCT03742037 | Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus | COMPLETED |
| PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis | Myasthénie | À vérifier | NCT07717281 | PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis | RECRUITING |
| BIIB059 (litifilimab) | Lupus | Phase 3 | NCT06044337 | AMETHYST LTE — A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus | ENROLLING_BY_INVITATION |
| Litifilimab | Lupus | Phase 2/3 | NCT05531565 | AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
| Neurosurgical Outcome Network | Épilepsie | À vérifier | NCT06724029 | Neurosurgical Outcome Network | RECRUITING |